A Modular Approach to Trisubstituted Chiral Piperidines.

Org Lett

Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We report a modular strategy for the synthesis of trisubstituted chiral piperidines. First, a scalable, chiral-pool synthesis of an orthogonally protected piperidine tricarboxylic acid diester was developed. This synthesis involves a formal 4 + 2 cyclization between choro-homoserine and acetylene dicarboxylate, followed by a diastereoselective reduction, cyclic anhydride formation, and regioselective ring-opening process to give the final product as a single enantio- and diastereomer at >50 g scale. Next, we demonstrated that the piperidine tricarboxylate intermediate can undergo sequential decarboxylative functionalizations using modern transition metal-catalyzed or photocatalytic methodologies. As the result, highly elaborated chiral piperidines and pipecolic esters were prepared in a chemo- and stereoselective manner.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.orglett.5c02419DOI Listing

Publication Analysis

Top Keywords

chiral piperidines
12
trisubstituted chiral
8
modular approach
4
approach trisubstituted
4
piperidines report
4
report modular
4
modular strategy
4
strategy synthesis
4
synthesis trisubstituted
4
piperidines scalable
4

Similar Publications

Rohitukine is a naturally occurring piperidine alkaloid that has led to the discovery of several potent CDK9/T1 inhibitors, including flavopiridol and IIIM-290. (-)-(3,4)-1-Methyl-4-(2,4,6-trimethoxyphenyl)-piperidin-3-ol serves as a crucial chiral intermediate in the synthesis of rohitukine and its analogues. In this paper, we describe the asymmetric synthesis of the chiral alcohol through the diastereoselective reduction of (+)-()-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidin-3-one in >90% yield and ≥99.

View Article and Find Full Text PDF

Piperidines and their 2-substituted derivatives are fundamental intermediates for the development of new active pharmaceutical ingredients with improved pharmacokinetic profiles and unique three-dimensional properties. Consequently, the design of synthetic methodologies for their selective transformations into highly valuable scaffolds, aimed at increasing the molecular diversity, is of high importance. We disclose herein a general and efficient organolithium-mediated protocol to promote chemo- and regioselective anionic Fries rearrangement or kinetic resolution processes starting from -aryl carbamates of 2-substituted piperidines.

View Article and Find Full Text PDF

The title compound, CHFNO·CHOH, is composed of a quinolinyl group and a piperidinyl group connected a hy-droxy-methine (-CHOH) functionality. The compound, which is monosolvated by methanol, was crystallized slow evaporation of a methanol solution, yielding colorless prism-like crystals. The hy-droxy-methine center of the compound is in the absolute configuration, whereas the chiral center of the piperidinyl ring is in the configuration.

View Article and Find Full Text PDF

A Modular Approach to Trisubstituted Chiral Piperidines.

Org Lett

August 2025

Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

We report a modular strategy for the synthesis of trisubstituted chiral piperidines. First, a scalable, chiral-pool synthesis of an orthogonally protected piperidine tricarboxylic acid diester was developed. This synthesis involves a formal 4 + 2 cyclization between choro-homoserine and acetylene dicarboxylate, followed by a diastereoselective reduction, cyclic anhydride formation, and regioselective ring-opening process to give the final product as a single enantio- and diastereomer at >50 g scale.

View Article and Find Full Text PDF

Tubulysins belong to a class of natural products originally isolated from myxobacteria culture and are known to induce cell apoptosis through inhibition of microtubule assembly. Herein, we report the computationally designed, structurally simplified, and first solid-phase peptide synthesis of novel third-generation tubulin inhibitors in high yields. These inhibitors are devoid of tubuvaline and tubuphenylalanine fragments previously considered essential for tubulin inhibition activity.

View Article and Find Full Text PDF